Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

Journal of Clinical Oncology

ISSN:
0732-183X
0
h-index
0
Citations
27
Works
0.00
2-year mean citedness

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
0358100120152017202220232024202520262015: Publications 1, Citations 02017: Publications 1, Citations 02022: Publications 2, Citations 02023: Publications 2, Citations 02024: Publications 7, Citations 02025: Publications 10, Citations 02026: Publications 4, Citations 0

Publication history

03581020152017202220232024202520262015: Publications 12017: Publications 12022: Publications 22023: Publications 22024: Publications 72025: Publications 102026: Publications 4

h-index evolution

Cumulative h-index by year

0120152017202220232024202520262015: h-index 02017: h-index 02022: h-index 02023: h-index 02024: h-index 02025: h-index 02026: h-index 0

Most-cited works

  1. Hormonal and genetic factors prognosis in gastric cancer.20150 citations
  2. Complex approach in the treatment of retroperitoneal fibrosarcoma.20170 citations
  3. Study of the level of tumor markers and mutations in the BRCA1/2 genes in breast cancer patients with metachronous tumors.20220 citations
  4. Study of the effectiveness of chemotherapy in patients with colorectal cancer depending on the location of the metastatic lesion.20220 citations
  5. Evaluation of the prevalence of HPV from environmentally unfavorable districts of the Republic of Karakalpakistan.20230 citations
  6. The role of molecular biomarker CDKN-2A in early diagnosis of colorectal cancer.20230 citations
  7. Burnout among GU oncologists and associated factors: BUCARE survey.20240 citations
  8. The efficacy of PARP inhibitors in the treatment of patients with synchronous breast cancer.20240 citations
  9. Possibilities of long-term atezolizumab immunotherapy in patients with metastatic urothelial cancer.20240 citations
  10. Immunohistochemical markers in the prognostic model for survival of patients with diffuse large B-cell lymphoma.20240 citations